Facial Pain Series - Part 1
Neurology Minute
In part one of this series, Dr. Derek Stitt discusses trigeminal neuralgia and, more specifically, how to make sure that's actually the diagnosis.
info_outline
October 26, 2026 Capitol Hill Report: Conrad 30
Neurology Minute
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN’s efforts to strengthen visa pathways for physicians serving communities across the US. Stay updated with what’s happening on the hill by visiting . Learn how you can get involved with .
info_outline
Youth Football and the Epidemic of Pediatric Brain Injury - Part 2
Neurology Minute
In part two of this series, Dr. Dara Albert and Isaac Thorman discuss guidance for parents weighing whether to let their children play tackle football. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:
info_outline
Youth Football and the Epidemic of Pediatric Brain Injury - Part 1
Neurology Minute
In part one of this series, Dr. Dara Albert and Isaac Thorman discuss football as a major contributor to pediatric traumatic brain injury and its association with subsequent head injuries. Show citation: Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:
info_outline
Acute Optic Neuropathy in Older Adults
Neurology Minute
Dr. Justin Abbatemarco discusses an article that helps us distinguish between the causes of acute optic neuropathy. Show citation: Tisavipat N, Stiebel-Kalish H, Palevski D, et al. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024;11(3):e200214. doi:
info_outline
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis
Neurology Minute
Dr. Aaron Zelikovich discusses how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis. Show citation: Gwathmey KG, Saccà F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi:
info_outline
Trends in Emergent Interfacility Ischemic Stroke Transfers
Neurology Minute
Dr. Andy Southerland and Dr. Matthew Gusler discuss how emergent interfacility transfers for ischemic stroke have changed and the factors associated with which patients are transferred. Show citation: Gusler MT, Deligkaris C, Zha AM, Burke JF. Trends in Emergent Interfacility Ischemic Stroke Transfers, 2016-2022. Neurology. 2026;107(7):e218499. doi:
info_outline
Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS
Neurology Minute
Dr. Zohaib Siddiqi and Dr. Michel Toledano discuss the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Show citation: Trentadue T, Martinez Sosa S, Itoh CY, et al. Clinical Reasoning: A 30-Year-Old Female Patient With Multiple Sclerosis Presenting With Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia. Neurology. 2025;105(12):e214429. doi:
info_outline
Optimizing Management of Episodic Cluster Headache
Neurology Minute
Dr. Tesha Monteith shares practical tips for improving outcomes for patients with episodic cluster headache.
info_outline
Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine
Neurology Minute
Dr. Tesha Monteith discusses growing evidence supporting CGRP-targeted therapies as first-line preventive treatment options for people with migraine. Show citation: Reuter U, Dycke AV, Versijpt J, et al. Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. Lancet Neurol. 2026;25(9):806-817. doi:
info_outlineIn this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN’s efforts to strengthen visa pathways for physicians serving communities across the US.
Stay updated with what’s happening on the hill by visiting aan.com/chr.
Learn how you can get involved with AAN advocacy.